Article
The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.
EMBO molecular medicine - 1 May 2015
Luna-Sánchez Marta, Díaz-Casado Elena, Barca Emanuele, Tejada Miguel Ángel, Montilla-García Ángeles, Cobos Enrique Javier, Escames Germaine, Acuña-Castroviejo Dario, Quinzii Catarina M, López Luis Carlos
Abstract excerpt
Primary coenzyme Q10 (CoQ10) deficiency is due to mutations in genes involved in CoQ biosynthesis. The disease has been associated with five major phenotypes, but a genotype-phenotype correlation is unclear. Here, we compare two mouse models with a genetic modification in Coq9 gene (Coq9(Q95X) and Coq9(R239X)), and their responses to 2,4-dihydroxybenzoic acid (2,4-diHB). Coq9(R239X) mice manifest severe...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
